Abstract
Tertiapin is a 21-residue peptide isolated from honey bee venoms. A recent study indicated that tertiapin is a potent blocker of certain types of inwardly rectifying K+ (Kir) channels (Jin and Lu, 1998). We examined the effect of tertiapin on ion channel currents in rabbit cardiac myocytes using the patch-clamp technique. In the whole-cell configuration, tertiapin fully inhibited acetylcholine (1 μM)-induced muscarinic K+ (KACh) channel currents in atrial myocytes with the half-maximum inhibitory concentration of ∼8 nM through ∼1:1 stoichiometry. The potency of tertiapin in inhibiting KACh channels was not significantly different at −40 and −100 mV. Tertiapin also inhibited the KACh channel preactivated by intracellular guanosine 5′-O-(3-thiotriphosphate), a nonhydrolyzable GTP analog. A constitutively active Kir channel, the IK1 channel, was at least 100 times less sensitive to tertiapin. Another Kir channel in cardiac myocytes, the ATP-sensitive K+ channel, was virtually insensitive to tertiapin (1 μM). The voltage-dependent K+ and the L-type Ca2+ channels were not affected by tertiapin (1 μM). At the single-channel level, tertiapin inhibited the KACh channel from the outside of the membrane by reducing the NPo (N is the number of functional channels, and the Po is the open probability of each channel) without affecting the single-channel conductance or fast kinetics. Therefore, tertiapin potently and selectively blocks the KACh channel in cardiac myocytes in a receptor- and voltage-independent manner. Tertiapin is a novel pharmacological tool to identify the functional role of the KACh channel in the parasympathetic regulation of the heart beat.
Footnotes
-
Send reprint requests to: Mitsuhiko Yamada, MD, PhD, Department of Cardiac Physiology, National Cardiovascular Center Research Institute, 5-7-1 Fujishiro-dai, Suita, Osaka 565-8565 Japan. E-mail: yamadacp{at}jsc.ri.ncvc.go.jp
-
↵1 This work was supported by a Research Grant for Cardiovascular Diseases (11C-1) from the Ministry of Health and Welfare of Japan and a grant from Japan Cardiovascular Research Foundation to M. Yamada.
- Abbreviations:
- Kir
- inwardly rectifying K+
- KACh
- muscarinic K+
- NPo
- product of the number of functional channels and the open probability of each channel
- EK
- potassium equilibration potential
- KATP
- ATP-sensitive K+
- GTPγS
- guanosine 5′-O-(3-thiotriphosphate)
- ICa
- voltage-dependent Ca2+ current: IK, voltage-dependent K+ current
- I-V
- current-voltage
- ACh
- acetylcholine
- Received October 27, 1999.
- Accepted December 21, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|